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Abstract 
 
In the absence of cardiac pathology, the presence of a dilated inferior vena cava (IVC) 
is considered idiopathic. To date this phenomenon has only been described in athletic 
individuals as an adaptation to chronically augmented venous return. This is the 
largest prospective cohort study, following ten individuals with idiopathic dilated IVC 
against an age matched control group with annual echocardiograms and cardiac 
magnetic resonance (CMR) imaging for a median of 55 months. No significant 
difference was found between echocardiography and CMR measurements in IVC 
diameter assessment both at baseline and at follow up. Over the study period there 
was no significant progression of the IVC in diameter as measured either by 
echocardiography or CMR. None of the patients suffered any cardiovascular events 
and there were no hospitalizations. Our findings indicate the benign nature of this 
condition and provide reassurance with regards to future clinical implications. 
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Introduction 
The inferior vena cava (IVC) is a highly compliant vessel that modulates its diameter 
and cross-sectional area in parallel with changes in blood volume. The IVC is dilated 
in patients with elevated right atrial pressure, right ventricular hypertrophy, tricuspid 
valve disease and pericardial constriction reflecting similar and parallel changes in 
central blood volume and capacitance. Aside from these volume dependent conditions 
the IVC can  also be dilated in otherwise healthy individuals. In the absence of any 
cardiac pathologic condition, the finding of a dilated IVC is considered primary or 
idiopathic1. The diagnosis of idiopathic dilated IVC is usually a diagnosis of 
exclusion usually performed by echocardiography and variably supported by 
additional non cardiac diagnostic tests. Overall, little is known about this condition 
mainly because it is encountered so infrequently. It is presumed that this vascular 
dilation maybe the effect of adaptation to chronically augmented venous return from 
the lower part of the body, causing increased volume load with increased cardiac 
output 1. Supporting this theory is that idiopathic dilatation of IVC (IDIVC), is usually 
encountered in young athletes.  
There are several cases of IDIVC that are also found in non-athletic or young and 
physically active individuals, arguing against a solely volume-related theory.  To 
acquire more understanding of this imaging finding we wished to evaluate 
consecutive patients with suspected idiopathic dilated IVC with comprehensive 
multimodality imaging and to serially follow up the  IVC dilatation to determine if 
there is any progression.   
 
 
 
3
Methods  
Patient Population 
We prospectively evaluated patients with suspected IDIVC initially screened by 
echocardiography. Eligible patients were identified from those referred to two major 
inner city tertiary centers for echocardiographic assessment from January 2009 to 
December 2014. Inclusion criteria were dilated IVC as defined by echocardiography 
(see below). Exclusion criteria were: echocardiographically assessed significant 
tricuspid valve disease defined as greater than mild severity , right ventricular 
dilatation or hypokinesia as defined by the American Society of Echocardiography 
2015 chamber quantification guidelines, prior history of cardiac disease, history of 
thromboembolic disease and pericardial disease. We have also excluded patients with 
known or suspected liver disease. To exclude concomitant intra-abdominal pathology 
(whether compressive of functional) as potential cause for venous stasis within the 
IVC all patients underwent comprehensive abdominal ultrasound and liver enzyme 
testing.   
Eligible patients underwent repeated transthoracic echocardiography and cardiac 
magnetic resonance at baseline (visit 1) and yearly thereafter.  
10 healthy volunteers matched for age and sex constituted the control group. They 
underwent baseline transthoracic echocardiography and CMR that was then compared 
to the case group. The study was approved by the local ethics committee.  
 
Echocardiography  
All patients underwent echocardiography in the left lateral decubitus position, using 
commercially available echocardiographic platforms (Philips iE 33, Philips Healthcare, 
Andover, MA) equipped with 2.5 Hz probe and all echocardiographic data were 
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subsequently digitally stored. Left atrial and ventricular diastolic diameters (LVDD), 
interventricular septal and posterior wall thickness (IVSTD and PWTD) were measured 
according to the guidelines of the American Society of Echocardiography2. The left 
ventricular volumes were measured by biplane 2D Simpson's method. The peak early 
(E) and late (A) transmitral flow velocities and deceleration time of E velocity were 
measured; the ratio of early-to-late peak velocities (E/A) was calculated. From tissue 
Doppler (TDI), the early diastolic (E′) at the septal corner of the mitral valve annulus 
was measured; the E/E′ ratio was calculated 
The patient was then placed in the supine position and the IVC diameter was determined 
in the long- and short-axis views in the subxiphoid approach 10 to 20 mm away from 
its junction to the right atrium3 (Figure 1a). The IVC was described as normal when its 
median diameter was 1.6 cm, dilated when median diameters were 1.7 to 2.5 cm, and 
very dilated when it was 2.6 cm or more4. This description of the IVC is a conjunction 
of 2010 American Society of Echocardiography and European Association of 
Echocardiography recommendations3. All measures reflect the median values between 
maximal inspiratory and expiratory values in 3 consecutive spontaneous respiratory 
cycles. IVC Doppler flow velocities were obtained in the subxiphoid approach in the 
hepatic vein near its junction to the IVC3 (Figure 1b). To assess IVC collapsibility, the 
phasic respiratory variation of IVC diameter was calculated as follows (IVCmax − 
IVCmin)/(IVCmax) ×100. All echocardiographic measurements took place over the same 
beats as per guidelines. 
 
Cardiac Magnetic Resonance (CMR) 
All patients were evaluated using a 1.5T scanner (Avanto, Siemens, Erlangen 
Germany). Cine images were obtained for assessment of mass and function using an 
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SSFP sequence in long-axis planes and short-axis slices from the mitral valve to the 
apex of the left ventricle as previously described5. The IVC was visualized and assessed 
in two views transverse and sagittal (Figure 2a and 2b respectively). To capture the 
phasic respiratory changes of IVC SSFP was used as preferred modality. As respiration 
and changes in intrathoracic and intra-abdominal pressures may also influence the 
volume and diameter of the IVC therefore to anticipate measurements at end inspiration 
and end expiration the maximum and minimum excursion of the diaphragm was used. 
The IVC diameter was measured 2 cm after the entry to right atrium in all successive 
scans.  As for the echocardiographic scan measures, these reflect the median values 
between maximal inspiratory and expiratory values in 3 consecutive spontaneous 
respiratory cycles. 
To assess the area and blood flow phase-contrast MRI was performed with velocity 
encoding magnetic resonance phase-contrast cine pulse sequence (TR, 27 ms; TE, 1.99 
ms; Flip angle, 25°; matrix, 256×256; field of view, 320 mm; section thickness, 8 mm, 
TSENSE rate 2) using retrospective electrocardiogram triggering. The velocity 
encoding gradient was adjusted to 150 cm/s without aliasing.  
 
Follow up 
All 10 study patients were longitudinally followed up for a median period of 55 months 
(minimum 42 months and maximum 60 months). All patients whilst included in the 
study had regular yearly clinical follow up where clinical examination was performed 
and routine bloods (where necessary) were taken. They underwent yearly 
echocardiography and CMR. Any possible cardiac event was cross verified and 
recorded. 
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Statistical Analysis 
Statistical analysis was performed using (SPSS). For comparison data between IDIVC 
and controls we used nonparametric analysis of variance (ANOVA) with subsequent 
Wilcoxon test.  Pairwise comparisons of IDIVC to either baseline or follow up 
parameters were performed using nonparametric Mann-Whitney test. Level of 
significance for pairwise comparisons was adjusted for multiple comparisons (p = 
0.05; 2 = 0.025). The coefficient of variation for all echocardiographic measurements 
was 3%. 
 
 
Reproducibility  
All IVC measurements took place at the same beats as per guidelines2. 
Reproducibility of IVC measurements during expiration and inspiration and the 
collapsibility index for all recordings was analyzed on 2 separate occasions within 
14±3 days for intra-observer variability and by a blinded investigator for interobserver 
variability. These assessments refer to echocardiography. The coefficient of variation 
for all echocardiographic measurements was 3%. Using Pearson’s coefficient a high 
correlation was found for both intra-observer and interobserver reliabilities (r = .94 
and .91, respectively). 
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Results 
During the predefined study period of 4 years we identified 10 patients (5 males and 5 
females) with dilated IVC fulfilling the inclusion and after the exclusion criteria. The 
mean age was 49 years and the median follow up was 55 months.  
The initial reason for referral to the echocardiography laboratory is described in Table 
1. Three of patients were considered as athletes (cyclists) based on their weekly 
aerobic activity but the rest were not engaged in any competitive physical activities.  
The mean IVC diameter dimension as assessed by echocardiography was 33mm in 
the dilated IVC group in comparison to 18mm in the control group (Table 2). An 
example of one the study patient’s dilated IVC by echocardiography is shown in 
figure 1a and 1b with and without color doppler respectively. Right heart 
echocardiographic data is provided in table 3 and CMR data in table 4. A transverse 
and sagittal orientation of a study patient’s dilated IVC by CMR is shown in figures 
2a and 2b respectively. Other than IVC measurements the remaining structural 
measurements between the study group and the control group showed no difference 
(Tables 2, 3 and 4). IVC measurements were complementary on CMR as with 
echocardiography as shown in Table 4. There were no differences between 
echocardiographic and CMR measurements in IVC diameter assessment both at 
baseline and final visit (Table 2 and Table 4). There was less distensibility seen in the 
dilated IVC group. The mean IVC area was assessed by CMR (Table 4). 
Importantly, over the study period there was no significant progression of IVC in 
diameter as measured either by echocardiography or CMR. None of the patients 
suffered any cardiovascular event during the follow up. There were no 
hospitalizations. 
Discussion 
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Our study, which is the largest contemporary study of IDIVC, adds two important 
pieces of additional information to the current knowledge of this infrequent disorder. 
First, that IDIVC could be found in non-athletic individuals and did not relate to sex or 
age. Second, the degree of IVC dilatation remained unchanged over time without 
significant progression. Our findings provide further support to the idiopathic and 
benign nature of this finding.  
 
The IVC is a highly collapsible major vein, and its diameter correlates closely with 
right side cardiac functions under normal RA pressure, the maximum IVC diameter is 
less than 22 mm, and the inspiratory collapse is more than 50%. Under high RA 
pressure, the IVC is dilated (more than 20 mm) and the inspiratory collapse of IVC is 
diminished. IVC diameter in young, healthy adults, without cardiac pathologic 
conditions, is frequently above 20 mm commonly regarded as an upper limit of normal 
and a noninvasive indication of increased right atrial pressure in patients with cardiac 
or renal disease6. Thus, it seems that dilated IVC should not be used as an indicator of 
increased right atrial pressure in healthy young adults3.  
Idiopathic dilatation of IVC remains a poorly understood, mainly echocardiographic 
finding usually encountered in young athletes1.  The finding of dilated IVC seems 
independent of the type of sport practiced and rather is related to the intensity of 
training, the number of training hours, which is the only accepted criterion to 
differentiate between subjects engaged in competitive sports and subjects practicing 
sport for leisure purposes1. In these circumstances it is assumed that this dilation 
represents a primary IVC adaptation to chronically augmented venous return from the 
lower part of the body, causing increased volume load with increased cardiac output.  
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In athletes, other factors may also contribute such as alterations in right ventricular 
structure due to adaptation and neurohumoral stimuli 1. 
Apart from athletes and physically trained subjects, IDIVC can be found in patients 
without cardiac disease, most of these are isolated case reports6-8. 
Apart from pericardial disease and intrinsic right ventricular disease, the differential 
diagnosis includes inferior vena cava aneurysms. Those are rare and although the  
diagnosis of aneurysms are more common in the elderly are associated with an increase 
in right sided heart pressures, significant TR, and RV dysfunction4. In our study we 
ascertained of the absent structural venous abnormalities by visualizing the entire 
length of IVC with MRI. 
In our study we identified 10 subjects during the 5 years of observation and after 
meticulous exclusion of alternative causes of dilated IVC. In contrast to prior reports 
only 3 of the patients could be considered as athletes while the rest were mostly 
sedentary. This finding along with normal cardiac intracavitary volumes compared to 
normal volunteers argues against the hypothesis of either increased venous return or 
cardiac adaptation as cause of dilated IVC. This finding is intriguing and adds to 
idiopathic nature of this imaging finding. Nevertheless, we found that the overall blood 
flow through the IVC was marginally albeit statistically significant higher in the dilated 
IVC group.  Perhaps, this may reflect increase blood flow due to larger size vessel. 
Importantly, we have shown that over time there was no evidence of progressive 
increase in IVC diameter or area as assessed by both echocardiography and cardiac 
MRI. Again, this finding is reassuring. Finally, during follow up none of the patients 
were hospitalized or suffered an adverse cardiovascular event.  
 
There are several limitations to this observational study. First, the highly selective 
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group of patients leads to inevitable degree of bias of observation. Second, we did not 
investigate a potential neuro hormonal etiology by blood sampling. Third, we did not 
assess directly the hematocrit or red cell mass as indirect index of increase blood 
volume. 
 
Conclusion 
In summary, our data suggests that IDIVC is a benign disorder without tendency to 
progression or increased morbidity. Our findings have implications to reduce 
implementation of future follow up for these patients as well as providing reassurance. 
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Table 1. Characteristics of cohort group with dilated inferior vena cava and 
reason for baseline echocardiogram  
Patient Reason for 
Referral 
Age (yrs) Sex BSA (m2) IVC mm 
1 
Orthopedic 
Surgery 
40 M 1.8 34 
2 
Exertional 
Dyspnea 
32 F 1.6 33 
3 
Gallbladder 
Surgery 
43 F 1.6 32 
4 Palpitations 31 F 1.4 33 
5 Palpitations 32 M 1.8 32 
6 
Insurance 
Requirement 
42 M 2.0 33 
7 Health Assessment 33 F 1.5 32 
8 
Non-cardiac Chest 
Pain 
35 F 1.6 32 
9 Health Assessment 34 F 1.8 31 
10 Health Assessment 25 M 1.9 32 
M Male and F Female, BSA body surface area, IVC inferior vena cava 
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Table 2. Parameters of Echocardiography at baseline and follow up of the study 
population. 
 
Parameters 
Study Patients  
Control (SD) 
 
P Value Baseline (SD) Final Visit (SD) 
SBP, mmHg 130 (7) 131 (4) 129 (5) ns 
DBP, mmHg 72 (5) 73 (5) 73 (4) ns 
Heart Rate, b/min 71 (4)  70 (5) 69 (5)  ns 
LVDD, cm 4.5 (0.4) 4.7 (0.3) 4.5 (0.1) ns 
LVSD, cm 2.6 (0.4) 2.8 (0.3) 2.7 (0.3) ns 
IST, cm 0.8 (0.1) 0.8 (0.1) 0.8 (0.2) ns 
PWT, cm 0.8 (0.1) 0.9 (0.1) 0.8 (0.1) ns 
LA, cm 3.3 (0.4)  3.5 (o.4 3.4 (0.5)  ns 
LV Mass, g 98 (10)  103 (11) 97 (12) ns 
E, cm/s 91 (16) 86 (15) 85 (10) ns 
A, cm/s 59 (9) 59 (11) 54 (11) ns 
E/A 1.58 (0.3) 1.59 (0.1) 1.58 (0.2) ns 
E’ lateral, cm/s 16 (2) 15 (5) 16 (4) ns 
E’ Septal, cm/s 11 (2) 12 (4) 11 (2) ns 
IVC, mm 33 (4) 32(4) 18 0.01 
IVC collapsibility, % 54 (3) 55 (4) 77 (4) 0.01 
Cardiac Output (L) 5.2 (0.5) 5.3 (0.3) 5.3 (0.7) 0.07 
SBP indicates systolic blood pressure, DBP systolic blood pressure, LVDD Left 
ventricular diastolic dimension, LSDD Left ventricular systolic dimension, IST 
interventricular septal thickness, PWT Posterior Wall Thickness, LA Left atrium, LV 
Mass Left ventricular Mass, IVC Inferior Vena Cava 
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Table 3. Right heart data  
 
Parameters 
Study patients, n=10  
Control, n=10 P value Baseline Final Visit 
RA (cm/m2) 
2.5 (0.9) 2.9 (0.7) 2.6 (0.9) ns 
RV diameter (cm) 
2.7 (0.9) 2.5 (0.5) 2.6 (0.4) ns 
TAPSE (mm) 
1.8(0.4) 1.9 (0.5) 1.7 (0,3) ns 
TR grade 
+1 +1 +1 ns 
RVSP (mmHg) 
18 (2) 20 (3) 18 (3) ns 
RA Right atrium, RV right ventricle, TAPSE tricuspid annular plane systolic 
excursion, TR tricuspid regurgitation, RVSP right ventricular systolic pressure 
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Table 4. Parameters of CMR at baseline and follow up of the study population 
compared to control group. 
 
Parameter 
Study patients  
Controls 
 
P Value Baseline Final Visit 
IVC, mm 33 (3) 32 (4) 17(2) 0.01 
IVC blood flow rate, l/min 2.2 (0.4) 2.3(0.5) 2.1 (0.7) 0.04 
IVC lumen area, cm2 2.9 (0.5) 3.0 (0.6) 2.1 (0.4) 0.01 
LV Mass, g 95 (5) 103 (4) 98 (10)  ns 
EF, % 63 (6) 62 (6) 61 (4) ns 
LVSV, ml 56 (8) 65 (11) 54 (9) ns 
LEDV, ml 99 (3) 103 (4) 100 (4)  ns 
LESV, ml 35 (7) 40 (8) 34 (6)  ns 
RVEF, % 45 (4) 44 (4) 45 (5) ns 
IVC Inferior Vena Cava, LVSV Left Ventricular Stroke Volume, LEDV Left end 
ventricular diastolic volume, LVSD Left ventricular systolic volume, LV Mass Left 
ventricular Mass, Right Ventricular Ejection Fraction 
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Figure Legends 
1. Example of dilated IVC by echocardiography 
1a. Two-dimensional subcostal long axis view 
1b. Colour Doppler of the subcostal long axis view 
IVC indicates Inferior Vena Cava, RA right atrium 
2. Example of dilated IVC by CMR 
2a. Transverse SSFP cine of the IVC and aorta 
2b. Sagittal SSFP cine showing the IVC and the aorta 
IVC indicates Inferior Vena Cava, Ao Aorta and SSFP Steady State Free 
Precession an echo MRI pulse sequence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17
